Fresenius Group Overview

Group Overview

Fresenius is a global healthcare group offering high-quality products and services for dialysis, hospitals, and outpatient treatment. With over 250,000 employees in more than 100 countries around the globe, and annual sales exceeding €25 billion, Fresenius is one of the world’s leading healthcare companies.

The Fresenius Group includes four independently operated business segments, each one active in a major growth area of healthcare. Fresenius Medical Care is the world leader in treating people with chronic kidney failure. Fresenius Helios is Germany’s largest hospital operator. Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services to help critically and chronically ill patients, while Fresenius Vamed plans, develops and manages healthcare facilities.

At Fresenius, the patient always comes first. For more than 100 years now we have been working to save lives and improve the quality of life of our patients. A clear focus on innovation and efficiency has helped us to make high-quality healthcare accessible to a steadily increasing number of people. Yet we never get complacent about our successes, and never stop looking for better solutions. This is how Fresenius is contributing to medical progress and better patient care.

Success in our business is the key for investing in high-quality yet affordable healthcare. In this way we are meeting our social responsibility to help patients, while ensuring that Fresenius remains successful over the long term.

Fresenius leads by recognizing important trends and developments early, then working with our partners to help shape healthcare systems. Aging populations and the expansion of healthcare provision in countries worldwide are driving demand for medical products and services, and Fresenius is excellently positioned to continue our strong growth into the future.

At Fresenius, “Forward Thinking Healthcare” captures our commitment to the future: better medicine for more people.

Fresenius Image Film


Fresenius Group in figures (IFRS)

 

€ in millions

 2016

2015

2014

Sales

 29,471

 27,995

23,459

EBIT

4,302

4,001

3,159

Operating cash flow

 3,585

3,349

2,560

Investments

2,559

2,051

3,770

Net income

 1,560

1,436

1,088

Employees (December 31)

 232,873

222,305

216,275

 

  • Some figures adjusted for special items
  • Following the closing of the Quirónsalud acquisition on January 31, 2017, Fresenius has more than 260,000 employees.
Group Sales by business segment

 

€ in millions

2016

2015

Change

Fresenius Medical Care 16,570
15,455
+ 7%
Fresenius Kabi 6,007
5,950
+ 1%
Fresenius Helios 5,843
5,578
+ 5%
Fresenius Vamed 1,160
1,118
+ 4%